We are champions!

This list brings together independent French companies that posted the strongest levels of growth for the 2015-2018 period. We are delighted to be part of it and to see the growth of our company and the increase in our activity. Indeed, this is only the beginning of a long adventure which begins in collaboration with French but also American biotechs to help them progress in drug research at an early stage.

A sincere thank you to our customers for their constantly renewed trust!

Read the article: => LesEchos<=

PhinC Development in figures:

Creation:2008
Workforce: 11
Support functions:6
Expert consultants:2
Subsidiary:1 (Montreal)
Share capital in €:100,000.00





 

 

Club Phase 1
GMP - Groupe de Métabolisme et Pharmacocinétique
EUFEMED
AFSSI